@article{ref1,
title="Drug treatment of bipolar disorder",
journal="Formulary",
year="1998",
author="Milner, K.K. and Amburgey, M.E. and Cameron, O.G.",
volume="33",
number="10",
pages="960-987",
abstract="Bipolar disorder is a psychiatric illness characterized by the episodic fluctuation of mood between mania or hypomania and depression. It afflicts nearly 1% of the US population and is associated with significant disruption of interpersonal relationships, loss of occupational status, and suicide. Psychopharmacologic agents have significantly decreased the morbidity and mortality associated with the disorder. In this article, the agents most commonly used for mood stabilization are discussed, addressing efficacy, side effect profiles, drug interactions, dosing, and administration. Adjunctive agents used for stabilization during the acute phases of the illness are reviewed, and new and novel agents that have shown promise in open clinical trials or case studies are identified.<p /><p>Language: en</p>",
language="en",
issn="1082-801X",
doi="",
url="http://dx.doi.org/"
}